Matthew Arnot Wright, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 17 years
- Harvard Medical School, 2009
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Wright’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A131194 · Current
Licensed to practise in California · since 2014 · expires 2028-03-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Child and Adolescent Psychiatry
- American Board of Psychiatry and Neurology - Psychiatry
Original Medicare doctor bills
$11,885
Medicare paid this office $11,885 for 23 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $7,670 | $59 |
Who their Medicare patients are
23 Original Medicare patients in 2024. Average age 54 · Women 52% · Health risk score 1.27. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 52% · Depression 48%.
The office billed $63,679, Medicare allowed $15,226 and paid $11,885; for 190 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 23 | 190 | 54 | 1.27 | $63,679 | $11,885 |
| 2023 | 22 | 37 | 57 | 1.22 | $11,680 | $2,729 |
| 2021 | 55 | 227 | 51 | 1.44 | $50,366 | $12,209 |
| 2020 | 18 | 63 | 55 | 1.44 | $18,401 | $3,969 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $911 | $61 |
2021: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $9,609 | $56 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,024 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $881 | $30 |
Drugs they prescribed that Part D paid
$223
Pharmacies billed $223 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 34) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
34 generic and 0 brand-name prescriptions · $223 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 34 | None | 0% (0) | 0% | $223 |
| 2023 | 29 | None | 0% (0) | 38% | $7,398 |
| 2022 | 18 | None | None | None | $2,000 |
| 2021 | 51 | 18 | None | None | $6,223 |
| 2020 | 36 | None | 0% (0) | None | $13,145 |
| 2019 | 76 | None | 0% (0) | None | $18,799 |
| 2018 | 70 | None | 0% (0) | None | $17,709 |
| 2017 | 79 | None | 0% (0) | 15% | $19,474 |
| 2016 | 91 | None | 0% (0) | 18% | $16,305 |
| 2015 | 91 | None | 0% (0) | 29% | $18,017 |
| 2014 | 31 | None | 0% (0) | None | $8,499 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 4 drugs
| Clomipramine | 11 | $3,653 | $332 |
| Fluoxetine | 12 | $121 | $10 |
| Terazosin | 13 | $111 | $9 |
| Clonazepam | 13 | $108 | $8 |
2018: 5 drugs
| Clomipramine | 11 | $5,853 | $532 |
| Gabapentin | 12 | $280 | $23 |
| Fluoxetine | 11 | $213 | $19 |
| Terazosin | 12 | $42 | $4 |
| Clonazepam | 11 | $24 | $2 |
2017: 3 drugs
| Invega | 12 | $12,441 | $1,037 |
| Gabapentin | 15 | $358 | $24 |
| Escitalopram | 13 | $132 | $10 |
2016: 5 drugs
| Invega | 12 | $11,425 | $952 |
| Memantine | 11 | $565 | $51 |
| Gabapentin | 15 | $344 | $23 |
| Escitalopram | 12 | $113 | $9 |
| Citalopram Hbr | 19 | $60 | $3 |
2015: 4 drugs
| Invega | 12 | $10,111 | $843 |
| Gabapentin | 12 | $644 | $54 |
| Escitalopram | 14 | $122 | $9 |
| Citalopram Hbr | 12 | $37 | $3 |
Money from drug and device companies
$144 in 2021
| 2021 | 1 | 1 | None | $144 |
| 2019 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Integra LifeSciences | Integra Meshed Bilayer Wound Matrix | $144 | 1 payment
|
See the published payment
| Integra LifeSciences | Meals · 2021-12-20 | Integra Meshed Bilayer Wound Matrix | $144 |
See earlier years (2019)
2019: $23
| Astellas Pharma US | Lexiscan | $23 | 1 payment
|
Professional record
- NPI
- 1003041559
- Licence
- CA A131194California A131194: Current · expires 2028-03-31
- Trained
- Harvard Medical School, 2009 · 17 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-05-27
- NPI last updated
- 2025-06-05
- NPI record certified
- 2025-06-05
This is when the NPI record was last certified, not a medical board exam.